ESC Professional Premium Access

Cardiac resynchronisation therapy and implantable cardioverter-defibrillator in non-ischaemic systolic heart failure: extended follow-up of the DANISH trial

Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)

Congress Session

About the speaker

Doctor Adelina Yafasova

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)
0 follower

5 more presentations in this session

Cardiac resynchronization therapy: association between genetically determinated dilated cardiomyopathy and dissinchronopathy

Speaker: Doctor M. Zecchin (Trieste, IT)


Impact of cardiac resynchronisation therapy in patients with cardiac sarcoidosis

Speaker: Doctor R. Ahmed (London, GB)


The impact of right ventricular size and function on long-term outcomes in patients undergoing cardiac resynchronization therapy

Speaker: Mr X. Galloo (Leiden, NL)


Biventricular or left univentricular pacing in heart failure patients: is there a better strategy

Speaker: Doctor M. Barradas (Ponta Delgada, PT)


Prediction of response to cardiac resynchronization therapy using cardiac magnetic resonance imaging in non-ischemic dilated cardiomyopathy

Speaker: Doctor S. Kim (Seoul, KR)


Access the full session

Heart failure: let’s re-synchronise please

Speakers: Doctor A. Yafasova, Doctor M. Zecchin, Doctor R. Ahmed, Mr X. Galloo, Doctor M. Barradas...

About the event


ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

This platform is supported by

logo Novo Nordisk